Baxter International Inc., headquartered in Deerfield, Illinois, provides a wide range of healthcare products worldwide. The company's broad portfolio includes dialysis therapies, infusion systems, and acute care products, serving hospitals and other medical facilities globally. Baxter's strategic partnerships and expansive sales network highlight its significant presence in the healthcare sector.
The fundamental rating for Baxter International Inc. reflects a moderate level of financial health, with particular strengths and weaknesses outlined in the table below.
Category | Score | Visualization |
---|---|---|
Overall Score | 2 | |
Discounted Cash Flow | 4 | |
Return on Equity | 1 | |
Return on Assets | 1 | |
Debt to Equity | 1 | |
Price to Earnings | 1 | |
Price to Book | 3 |
The historical ratings provide insight into the trend of Baxter's financial performance. The stability of certain scores over time can be indicative of consistent financial management.
Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-09-15 | 2 | 4 | 1 | 1 | 1 | 1 | 3 |
N/A | 0 | 4 | 1 | 1 | 1 | 1 | 3 |
Analysts have set various price targets for Baxter, reflecting differing opinions on future performance. The following table summarizes these targets.
High | Low | Median | Consensus |
---|---|---|---|
36 | 24 | 30 | 30 |
Analyst sentiment indicates a predominantly cautious approach to Baxter's future performance, as demonstrated by the distribution of recommendations below.
Recommendation | Number | Visualization |
---|---|---|
Strong Buy | 0 | |
Buy | 15 | |
Hold | 20 | |
Sell | 1 | |
Strong Sell | 0 |
Baxter International Inc. demonstrates a moderate stability in key financial metrics, though areas like Return on Equity and Return on Assets are weak. The analyst consensus leans toward holding the stock, reflecting uncertainty about significant short-term growth. The price targets indicate potential for modest gains. Overall, investing in Baxter may be suitable for those seeking long-term exposure to the healthcare sector, balancing potential rewards with inherent financial risks.